tiprankstipranks
Trending News
More News >
SinoMab Bioscience Ltd. (HK:3681)
:3681
Hong Kong Market

SinoMab Bioscience Ltd. (3681) Financial Statements

Compare
1 Followers

SinoMab Bioscience Ltd. Financial Overview

SinoMab Bioscience Ltd.'s market cap is currently HK$2.35B. The company's EPS TTM is HK$-0.055; its P/E ratio is -11.90; SinoMab Bioscience Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 2.03M¥ 1.36M¥ 4.03M¥ 26.66M¥ 12.76M
Gross Profit¥ 543.00K¥ 422.00K¥ 4.03M¥ 26.66M¥ 12.76M
Operating Income¥ -161.35M¥ -229.57M¥ -258.93M¥ -305.86M¥ -162.65M
EBITDA¥ -142.79M¥ -200.46M¥ -244.29M¥ -296.43M¥ -158.61M
Net Income¥ -185.14M¥ -243.11M¥ -284.16M¥ -288.19M¥ -122.60M
Balance Sheet
Cash & Short-Term Investments¥ 106.88M¥ 234.66M¥ 376.19M¥ 589.53M¥ 916.20M
Total Assets¥ 753.10M¥ 847.79M¥ 1.01B¥ 1.04B¥ 1.13B
Total Debt¥ 482.27M¥ 450.81M¥ 357.18M¥ 275.46M¥ 97.84M
Net Debt¥ 420.37M¥ 247.14M¥ 11.47M¥ -287.52M¥ -712.53M
Total Liabilities¥ 560.19M¥ 552.20M¥ 498.77M¥ 361.43M¥ 142.51M
Stockholders' Equity¥ 192.91M¥ 295.58M¥ 509.57M¥ 680.23M¥ 987.01M
Cash Flow
Free Cash Flow¥ -172.30M¥ -237.74M¥ -413.29M¥ -345.30M¥ -217.29M
Operating Cash Flow¥ -130.80M¥ -133.85M¥ -300.54M¥ -147.06M¥ -141.34M
Investing Cash Flow¥ -94.48M¥ -96.92M¥ -81.36M¥ -137.70M¥ -179.22M
Financing Cash Flow¥ 73.27M¥ 82.27M¥ 102.28M¥ 57.52M¥ -18.81M
Currency in CNY

SinoMab Bioscience Ltd. Earnings and Revenue History

SinoMab Bioscience Ltd. Debt to Assets

SinoMab Bioscience Ltd. Cash Flow

SinoMab Bioscience Ltd. Forecast EPS vs Actual EPS